Center for Digestive and Liver Diseases, Inc.
Mexico, Missouri 65265
0 studies enrolling now · 12 studies all time
What they study most
Colitis, Ulcerative, Colorectal Cancer, Colorectal Neoplasms, Crohn's Disease, Delayed Gastric Emptying, Diabetes, Diabetes Mellitus, Diabetic Gastroparesis, Diarrhea Predominant Irritable Bowel Syndrome, Gastroparesis, Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome
Studies at this site
- Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis — Completed
- Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease — Completed
- A Study To Monitor Long-Term Treatment With PF-00547659 — Completed
- Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis — Completed
- Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease — Completed
- A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis — Completed
- Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease — Completed
- Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis — Completed
- Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis — Completed
- Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) — Completed
- LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) — Completed
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females — Status unconfirmed